openPR Logo
Press release

US Indapamide Market Size, Growth, Trends, Share, Forecast 2020-2026

08-07-2020 04:52 PM CET | Health & Medicine

Press release from: Orion Market Research

US Indapamide Market

US Indapamide Market

US indapamide market is estimated to grow significantly during the forecast period. The significant prevalence of hypertension along with the CVD and high healthcare expenditure is primarily contributing to the market growth in the region. According to the Center for Medicare and Medicaid Services, in 2018, the US national healthcare expenditure was around $3.6 trillion showing a 4.4% increase in healthcare expenditure up from 3.9% in 2017. It is further expected to reach $6.0 trillion by 2027.

Request a Free Sample of our Report on US Indapamide Market: https://www.omrglobal.com/request-sample/us-indapamide-market

The US has the highest healthcare spending across the globe. CVD and strokes accounted for 14% of the total healthcare expenditure. Around 1 in 19 mortalities in the US were due to stroke in the country in 2017 causing more than 146,000 mortalities. In the US, the per capita healthcare expenditure per person in 2018 was around $10,800. Thus, high expenditure is likely to support the growth of the market.

The US indapamide market is segmented on the basis of product and application. Based on product, the market is bifurcated into 1.25 mg and 2.5 mg. Among these, the market for 1.25 mg medicine held the significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have significant share in the market. Growing incidence of hypertension is contributing to market growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions.

A Full Report of US Indapamide Market is Available at https://www.omrglobal.com/industry-reports/us-indapamide-market

US Indapamide Market Segmentation

By Product
• 1.25 MG
• 2.5 MG

By Application
• High Blood Pressure
• Heart Failure
• Others

Company Profiles
• ANI Pharmaceuticals, Inc.
• Apotex Inc.
• Glenmark Pharmaceuticals Ltd.
• Krka Group
• Mylan N.V.
• Preferred Pharmaceuticals, Inc.
• Sanis Health Inc.
• Sanofi S.A.
• Teva Pharmaceuticals Industries Ltd.
• Servier Group

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-indapamide-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Indapamide Market Size, Growth, Trends, Share, Forecast 2020-2026 here

News-ID: 2106974 • Views:

More Releases from Orion Market Research

Digital Innovation in Insurance Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Digital Innovation in Insurance Market Size Analysis, Competitive Insights, Lead …
The Global Digital Innovation in Insurance Market is projected to reach around USD 250 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 9.5% from 2024 to 2033. Digital Innovation in Insurance Market Overview The Digital Innovation in Insurance Market encompasses the integration of advanced technologies such as Artificial Intelligence (AI), Blockchain, the Internet of Things (IoT), and Big Data analytics into the insurance sector. These innovations are
Cigarette Rolling Paper Market - Industry Trends and Forecast to 2033
Cigarette Rolling Paper Market - Industry Trends and Forecast to 2033
The Global Cigarette Rolling Paper Market was valued at approximately USD 2.9 billion in 2024 and is projected to reach around USD 41.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 34.5% from 2024 to 2033. Cigarette Rolling Paper Market Overview The Global Cigarette Rolling Paper Market has experienced significant growth, driven by increasing consumer preference for hand-rolled cigarettes, particularly among younger and budget-conscious smokers. These papers
Back Glue Market: Emerging Trends and Growth Forecast to 2033
Back Glue Market: Emerging Trends and Growth Forecast to 2033
The Global Back Glue Market is projected to reach around USD 3.0 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 7.1% from 2024 to 2033. Back Glue Market Overview The Global Back Glue Market encompasses adhesives designed for various applications, including bookbinding, phone back panels, and other industrial uses. Advancements in technology have led to the development of high-performance back glue adhesives, which are anticipated to drive
Autopilot Systems Market Overview: Growth, Share, Value, Size, and Scope
Autopilot Systems Market Overview: Growth, Share, Value, Size, and Scope
The Global Autopilot Systems Market was valued at approximately USD 5.8 billion in 2023 and is projected to reach around USD 10.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 6.4% from 2024 to 2033. Autopilot Systems Market Overview The Global Autopilot Systems Market encompasses advanced flight control systems designed to automate the navigation and operation of aircraft, reducing the need for manual input by pilots. These

All 5 Releases


More Releases for Indapamide

Indapamide Market Increasing Demand, Growth Analysis and Future Outlook by 2031
The global indapamide market is estimated to grow significantly at a CAGR of over 2.0% during the forecast period. A significant rise in the incidences of high blood pressure (hypertension) and congestive heart failure is primarily contributing to the growth of the market. High blood pressure affects approximately a third of the adult population across the globe and is the most common cause of CVD-related mortalities. As per the data
Asia-Pacific Indapamide Market
Asia-Pacific indapamide market is estimated to grow significantly at a CAGR of around 3.8% during the forecast period owing to the increasing prevalence of chronic disorders, including hypertension, CVD, and diabetes. The rising incidences of these diseases have been reported in several countries of Asia-Pacific, including China, India, and Singapore. For instance, in India, one in five young adults has high blood pressure, according to the data presented at the
LAMEA Indapamide Market Size, Share, Impressive Industry Growth, Analysis Report …
The LAMEA indapamide market is estimated to grow significantly during the forecast period. The factors contributing to the growth of the indapamide market include rising cases of diabetes and hypertension among the population. According to the International Diabetes Federation (IDF), Brazil and Mexico are the two countries with a higher number of diabetes cases registered in the region. In Mexico, an estimated 12 million cases were registered in 2017. Additionally,
Japan Indapamide MarketSize, Industry Trends, Share and Forecast 2020-2026
apan indapamide market is estimated to grow at a CAGR of around 1.7% during the forecast period. The growth is attributed to the rising number of hypertension and diabetes patients in the country. As per the IDF, in 2019, the total cases of diabetes in adults were 7.4 million, which accounted for nearly 7.9% of the total adult population in the country. The factors that are contributing to the increasing
North American Indapamide Market Trends, Growth, Analysis and Forecast - 2025
North American indapamide market is estimated to grow significantly at a CAGR of around 0.3% during the forecast period. The market is mainly growing due to the rising prevalence of hypertension and CVD such as heart strokes, blood pressure, arrhythmias among others. According to the Heart & Stroke Foundation in Canada (2017), 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart
UK Indapamide Market Growth, Trends, Industry Analysis and Forecast - 2025
UK indapamide market is estimated to grow significantly at a CAGR of around 2.4% during the forecast period. A significant prevalence of CVDs has been witnessed in the country. According to the British Heart Foundation, more than one-fourth of the fatalities in UK occur due to CVDs, and it is responsible for around 1.6 million fatalities each year. Moreover, more than 7 million people live with one or the other